Will this new drug change the way we manage and understand Alzheimer’s?
Written by Diana Ortega Cruz
In June of 2021, the US Food and Drug Administration (FDA) approved aducanumab, the first drug for the treatment of Alzheimer’s Disease (AD) that targets…
Read more
